Nikhil I Khushalani Selected Research

Nikhil I Khushalani Research Topics

Disease

36	Melanoma (Melanoma, Malignant) 04/2022 - 04/2013
20	Neoplasms (Cancer) 01/2022 - 03/2010
9	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2003
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 12/2016
5	Brain Neoplasms (Brain Tumor) 10/2022 - 08/2018
4	Carcinoma (Carcinomatosis) 04/2014 - 06/2002
4	Esophageal Neoplasms (Esophageal Cancer) 06/2012 - 06/2002
3	Body Weight (Weight, Body) 08/2018 - 02/2014
2	Colitis 12/2021 - 11/2020
2	Neurologic Manifestations (Neurological Manifestations) 11/2021 - 08/2018
2	Merkel Cell Carcinoma 01/2021 - 10/2019
2	Uveal melanoma 11/2020 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2018 - 04/2015
2	Fatigue 01/2018 - 04/2015
2	Neutropenia 04/2015 - 08/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 02/2015 - 05/2014
1	Hypophysitis 12/2021
1	Disease Progression 12/2021
1	Pain (Aches) 01/2021
1	Pneumonia (Pneumonitis) 11/2020
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2020
1	Drug-Related Side Effects and Adverse Reactions 11/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2019
1	Extranodal Extension 06/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Inflammatory Bowel Disease 2 02/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2016
1	Multiple Sclerosis 02/2016
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 02/2016
1	Autoimmune Diseases (Autoimmune Disease) 02/2016
1	Rheumatoid Arthritis 02/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2016
1	Granular Cell Tumor 10/2015
1	Hemangiosarcoma (Angiosarcoma) 06/2015
1	Kidney Neoplasms (Kidney Cancer) 05/2014
1	Lymphatic Metastasis 04/2014

Drug/Important Bio-Agent (IBA)

17	IpilimumabIBA 01/2022 - 04/2013
12	NivolumabIBA 03/2022 - 04/2015
9	Immune Checkpoint InhibitorsIBA 03/2022 - 04/2015
6	cemiplimabIBA 01/2021 - 01/2018
5	pembrolizumabIBA 01/2022 - 12/2016
4	Interleukin-2 (IL2)IBA 01/2021 - 05/2014
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 11/2018
4	VemurafenibIBA 11/2020 - 04/2013
3	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2012 - 06/2002
2	AntigensIBA 10/2022 - 11/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 11/2021
2	bempegaldesleukinIBA 03/2022 - 10/2020
2	Alanine Transaminase (SGPT)IBA 12/2021 - 04/2015
2	trametinibIBA 11/2020 - 05/2014
2	dabrafenibIBA 11/2020 - 05/2014
2	Monoclonal AntibodiesIBA 01/2020 - 11/2019
2	Lipase (Acid Lipase)FDA Link 01/2018 - 04/2015
2	peginterferon alfa-2b (Pegintron)FDA Link 01/2016 - 04/2013
2	Pharmaceutical PreparationsIBA 04/2015 - 01/2014
2	CreatinineIBA 09/2010 - 03/2010
2	Fluorouracil (Carac)FDA LinkGeneric 11/2002 - 06/2002
1	Bispecific AntibodiesIBA 10/2022
1	Mitogen-Activated Protein KinasesIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	ibrutinibIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	binimetinibIBA 11/2020
1	cobimetinibIBA 11/2020
1	encorafenibIBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Cell Surface ReceptorsIBA 11/2019
1	Peptides (Polypeptides)IBA 11/2019
1	Radioisotopes (Radionuclides)IBA 11/2019
1	Type 1 Melanocortin ReceptorIBA 01/2019
1	LigandsIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018
1	CytokinesIBA 11/2018
1	afliberceptIBA 11/2018
1	InterferonsIBA 06/2018
1	methylallyl trisulfide (MATS)IBA 05/2018
1	Amylases FDA Link 01/2018
1	Sunitinib (Sutent)FDA Link 01/2018
1	talimogene laherparepvecIBA 12/2016
1	pazopanib FDA Link 10/2015
1	Immunoglobulin G (IgG)IBA 04/2015
1	B7-H1 AntigenIBA 02/2015
1	aldesleukin (Proleukin)FDA Link 02/2015

Therapy/Procedure

35	Therapeutics 10/2022 - 08/2008
8	Immunotherapy 10/2022 - 04/2015
8	Drug Therapy (Chemotherapy) 06/2021 - 11/2002
7	Radiotherapy 01/2017 - 06/2002
4	Neoadjuvant Therapy 11/2020 - 06/2015
2	Lymph Node Excision (Lymph Node Dissection) 10/2022 - 05/2014
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2022 - 01/2021
2	Adjuvant Radiotherapy 10/2018 - 03/2009
2	Nephrectomy 02/2015 - 05/2014
1	Castration 11/2019
1	Aftercare (After-Treatment) 01/2017
1	Esophagectomy 04/2014